 | • レポートコード：D0GIR-01674 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ループス腎炎の世界市場を広く調査・分析し、今後の市場展望をまとめております。ループス腎炎の種類別市場規模（診断、薬）、用途別市場規模（病院、クリニック、外来手術センター、製薬会社）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Eli Lilly、Merck、Bristol-Myers Squibb、myVMC、GlaxoSmithKline ・地域別グローバル市場分析 2015年-2020年 ・ループス腎炎の北米市場（アメリカ、カナダ、メキシコ） ・ループス腎炎のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ループス腎炎のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ループス腎炎の南米市場（ブラジル、アルゼンチン） ・ループス腎炎の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：診断、薬 ・用途別分析：病院、クリニック、外来手術センター、製薬会社 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Lupus Nephritis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Lupus Nephritis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Lupus Nephritis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Lupus Nephritis market has been segmented into:
Diagnose
Medications
By Application, Lupus Nephritis has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Pharmaceutical Companies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lupus Nephritis market presented in the report. This section sheds light on the sales growth of different regional and country-level Lupus Nephritis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lupus Nephritis market.
The report offers in-depth assessment of the growth and other aspects of the Lupus Nephritis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Lupus Nephritis Market Share Analysis
Lupus Nephritis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lupus Nephritis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lupus Nephritis sales, revenue and market share for each player covered in this report.
The major players covered in Lupus Nephritis are:
Roche
Eli Lilly
Merck
Bristol-Myers Squibb
myVMC
GlaxoSmithKline
Table of Contents
1 Lupus Nephritis Market Overview
1.1 Product Overview and Scope of Lupus Nephritis
1.2 Classification of Lupus Nephritis by Type
1.2.1 Global Lupus Nephritis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Lupus Nephritis Revenue Market Share by Type in 2019
1.2.3 Diagnose
1.2.4 Medications
1.3 Global Lupus Nephritis Market by Application
1.3.1 Overview: Global Lupus Nephritis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Pharmaceutical Companies
1.4 Global Lupus Nephritis Market by Regions
1.4.1 Global Lupus Nephritis Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Lupus Nephritis (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Lupus Nephritis Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Lupus Nephritis Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lupus Nephritis Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Lupus Nephritis Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lupus Nephritis Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Lupus Nephritis Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly SWOT Analysis
2.2.4 Eli Lilly Product and Services
2.2.5 Eli Lilly Lupus Nephritis Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Lupus Nephritis Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol-Myers Squibb SWOT Analysis
2.4.4 Bristol-Myers Squibb Product and Services
2.4.5 Bristol-Myers Squibb Lupus Nephritis Revenue, Gross Margin and Market Share (2018-2019)
2.5 myVMC
2.5.1 myVMC Details
2.5.2 myVMC Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 myVMC SWOT Analysis
2.5.4 myVMC Product and Services
2.5.5 myVMC Lupus Nephritis Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline Lupus Nephritis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Lupus Nephritis Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Lupus Nephritis Players Market Share
3.2.2 Top 10 Lupus Nephritis Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Lupus Nephritis Revenue and Market Share by Regions
4.2 North America Lupus Nephritis Revenue and Growth Rate (2015-2020)
4.3 Europe Lupus Nephritis Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Lupus Nephritis Revenue and Growth Rate (2015-2020)
4.5 South America Lupus Nephritis Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Lupus Nephritis Revenue and Growth Rate (2015-2020)
5 North America Lupus Nephritis Revenue by Countries
5.1 North America Lupus Nephritis Revenue by Countries (2015-2020)
5.2 USA Lupus Nephritis Revenue and Growth Rate (2015-2020)
5.3 Canada Lupus Nephritis Revenue and Growth Rate (2015-2020)
5.4 Mexico Lupus Nephritis Revenue and Growth Rate (2015-2020)
6 Europe Lupus Nephritis Revenue by Countries
6.1 Europe Lupus Nephritis Revenue by Countries (2015-2020)
6.2 Germany Lupus Nephritis Revenue and Growth Rate (2015-2020)
6.3 UK Lupus Nephritis Revenue and Growth Rate (2015-2020)
6.4 France Lupus Nephritis Revenue and Growth Rate (2015-2020)
6.5 Russia Lupus Nephritis Revenue and Growth Rate (2015-2020)
6.6 Italy Lupus Nephritis Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Lupus Nephritis Revenue by Countries
7.1 Asia-Pacific Lupus Nephritis Revenue by Countries (2015-2020)
7.2 China Lupus Nephritis Revenue and Growth Rate (2015-2020)
7.3 Japan Lupus Nephritis Revenue and Growth Rate (2015-2020)
7.4 Korea Lupus Nephritis Revenue and Growth Rate (2015-2020)
7.5 India Lupus Nephritis Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Lupus Nephritis Revenue and Growth Rate (2015-2020)
8 South America Lupus Nephritis Revenue by Countries
8.1 South America Lupus Nephritis Revenue by Countries (2015-2020)
8.2 Brazil Lupus Nephritis Revenue and Growth Rate (2015-2020)
8.3 Argentina Lupus Nephritis Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Lupus Nephritis by Countries
9.1 Middle East & Africa Lupus Nephritis Revenue by Countries (2015-2020)
9.2 Saudi Arabia Lupus Nephritis Revenue and Growth Rate (2015-2020)
9.3 UAE Lupus Nephritis Revenue and Growth Rate (2015-2020)
9.4 Egypt Lupus Nephritis Revenue and Growth Rate (2015-2020)
9.5 South Africa Lupus Nephritis Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Lupus Nephritis Revenue and Market Share by Type (2015-2020)
10.2 Global Lupus Nephritis Market Forecast by Type (2019-2024)
10.3 Diagnose Revenue Growth Rate (2015-2025)
10.4 Medications Revenue Growth Rate (2015-2025)
11 Global Lupus Nephritis Market Segment by Application
11.1 Global Lupus Nephritis Revenue Market Share by Application (2015-2020)
11.2 Lupus Nephritis Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.6 Pharmaceutical Companies Revenue Growth (2015-2020)
12 Global Lupus Nephritis Market Size Forecast (2021-2025)
12.1 Global Lupus Nephritis Market Size Forecast (2021-2025)
12.2 Global Lupus Nephritis Market Forecast by Regions (2021-2025)
12.3 North America Lupus Nephritis Revenue Market Forecast (2021-2025)
12.4 Europe Lupus Nephritis Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Lupus Nephritis Revenue Market Forecast (2021-2025)
12.6 South America Lupus Nephritis Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Lupus Nephritis Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Lupus Nephritis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lupus Nephritis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lupus Nephritis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Lupus Nephritis Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Corporate Information, Location and Competitors
Table 6. Roche Lupus Nephritis Major Business
Table 7. Roche Lupus Nephritis Total Revenue (USD Million) (2017-2018)
Table 8. Roche SWOT Analysis
Table 9. Roche Lupus Nephritis Product and Solutions
Table 10. Roche Lupus Nephritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Eli Lilly Corporate Information, Location and Competitors
Table 12. Eli Lilly Lupus Nephritis Major Business
Table 13. Eli Lilly Lupus Nephritis Total Revenue (USD Million) (2018-2019)
Table 14. Eli Lilly SWOT Analysis
Table 15. Eli Lilly Lupus Nephritis Product and Solutions
Table 16. Eli Lilly Lupus Nephritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck Lupus Nephritis Major Business
Table 19. Merck Lupus Nephritis Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck Lupus Nephritis Product and Solutions
Table 22. Merck Lupus Nephritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 24. Bristol-Myers Squibb Lupus Nephritis Major Business
Table 25. Bristol-Myers Squibb Lupus Nephritis Total Revenue (USD Million) (2017-2018)
Table 26. Bristol-Myers Squibb SWOT Analysis
Table 27. Bristol-Myers Squibb Lupus Nephritis Product and Solutions
Table 28. Bristol-Myers Squibb Lupus Nephritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. myVMC Corporate Information, Location and Competitors
Table 30. myVMC Lupus Nephritis Major Business
Table 31. myVMC Lupus Nephritis Total Revenue (USD Million) (2017-2018)
Table 32. myVMC SWOT Analysis
Table 33. myVMC Lupus Nephritis Product and Solutions
Table 34. myVMC Lupus Nephritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. GlaxoSmithKline Corporate Information, Location and Competitors
Table 36. GlaxoSmithKline Lupus Nephritis Major Business
Table 37. GlaxoSmithKline Lupus Nephritis Total Revenue (USD Million) (2017-2018)
Table 38. GlaxoSmithKline SWOT Analysis
Table 39. GlaxoSmithKline Lupus Nephritis Product and Solutions
Table 40. GlaxoSmithKline Lupus Nephritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Lupus Nephritis Revenue (Million USD) by Players (2015-2020)
Table 42. Global Lupus Nephritis Revenue Share by Players (2015-2020)
Table 43. Global Lupus Nephritis Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Lupus Nephritis Revenue Market Share by Regions (2015-2020)
Table 45. North America Lupus Nephritis Revenue by Countries (2015-2020)
Table 46. North America Lupus Nephritis Revenue Market Share by Countries (2015-2020)
Table 47. Europe Lupus Nephritis Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Lupus Nephritis Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Lupus Nephritis Revenue by Countries (2015-2020)
Table 50. South America Lupus Nephritis Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Lupus Nephritis Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Lupus Nephritis Revenue Market Share by Countries (2015-2020)
Table 53. Global Lupus Nephritis Revenue (Million USD) by Type (2015-2020)
Table 54. Global Lupus Nephritis Revenue Share by Type (2015-2020)
Table 55. Global Lupus Nephritis Revenue Forecast by Type (2021-2025)
Table 56. Global Lupus Nephritis Revenue by Application (2015-2020)
Table 57. Global Lupus Nephritis Revenue Share by Application (2015-2020)
Table 58. Global Lupus Nephritis Revenue Forecast by Application (2021-2025)
Table 59. Global Lupus Nephritis Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Lupus Nephritis Picture
Figure 2. Global Lupus Nephritis Revenue Market Share by Type in 2019
Figure 3. Diagnose Picture
Figure 4. Medications Picture
Figure 5. Lupus Nephritis Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Ambulatory Surgical Centers Picture
Figure 9. Pharmaceutical Companies Picture
Figure 10. Global Lupus Nephritis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Lupus Nephritis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Lupus Nephritis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Lupus Nephritis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Lupus Nephritis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Lupus Nephritis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Lupus Nephritis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Lupus Nephritis Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Lupus Nephritis Revenue Market Share in 2019
Figure 19. Global Top 10 Players Lupus Nephritis Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Lupus Nephritis Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Lupus Nephritis Revenue Market Share by Regions (2015-2020)
Figure 23. Global Lupus Nephritis Revenue Market Share by Regions in 2018
Figure 24. North America Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 25. Europe Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 27. South America Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 29. North America Lupus Nephritis Revenue Market Share by Countries (2015-2020)
Figure 30. North America Lupus Nephritis Revenue Market Share by Countries in 2019
Figure 31. USA Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 32. Canada Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 34. Europe Lupus Nephritis Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Lupus Nephritis Revenue Market Share by Countries in 2019
Figure 36. Germany Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 37. UK Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 38. France Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 39. Russia Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 40. Italy Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Lupus Nephritis Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Lupus Nephritis Revenue Market Share by Countries in 2019
Figure 43. China Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 44. Japan Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 45. Korea Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 46. India Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 48. South America Lupus Nephritis Revenue Market Share by Countries (2015-2020)
Figure 49. South America Lupus Nephritis Revenue Market Share by Countries in 2019
Figure 50. Brazil Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Lupus Nephritis Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Lupus Nephritis Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 55. UAE Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Lupus Nephritis Revenue and Growth Rate (2015-2020)
Figure 58. Global Lupus Nephritis Revenue Share by Type (2015-2020)
Figure 59. Global Lupus Nephritis Revenue Share by Type in 2019
Figure 60. Global Lupus Nephritis Market Share Forecast by Type (2021-2025)
Figure 61. Global Diagnose Revenue Growth Rate (2015-2020)
Figure 62. Global Medications Revenue Growth Rate (2015-2020)
Figure 63. Global Lupus Nephritis Revenue Share by Application (2015-2020)
Figure 64. Global Lupus Nephritis Revenue Share by Application in 2019
Figure 65. Global Lupus Nephritis Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 67. Global Clinics Revenue Growth Rate (2015-2020)
Figure 68. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 69. Global Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 70. Global Lupus Nephritis Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Lupus Nephritis Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Lupus Nephritis Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Lupus Nephritis Revenue Market Forecast (2021-2025)
Figure 74. Europe Lupus Nephritis Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Lupus Nephritis Revenue Market Forecast (2021-2025)
Figure 76. South America Lupus Nephritis Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Lupus Nephritis Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
皮膚エリテマトーデス（CLE）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cutaneous Lupus Erythematosus (CLE) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…- 皮膚エリテマトーデス治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cutaneous Lupus Erythematosus Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…
- 腎臓病治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Kidney Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 自己免疫治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Autoimmune Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Autoimmune Drugs market repo…
- 胸膜生検の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Pleural Biopsy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pleural Biopsy market report p…